TGF‐β1/Smad2/3 signaling pathway modulates octreotide antisecretory and antiproliferative effects in pituitary somatotroph tumor cells-Reference-Cited by-同舟云学术

TGF‐β1/Smad2/3 signaling pathway modulates octreotide antisecretory and antiproliferative effects in pituitary somatotroph tumor cells

Published:2021-03-08 Issue:10 Volume:236 Page:6974-6987
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Picech Florencia¹,Sosa Liliana DV.¹,Perez Pablo A.¹,Cecenarro Laura¹,Oms Sergio R.²,Coca Hugo A.³,De Battista Juan C.³,Gutiérrez Silvina¹^ORCID,Mukdsi Jorge H.¹,Torres Alicia I.¹,Petiti Juan P.¹^ORCID

Affiliation:

1. Instituto de Investigaciones en Ciencias de la Salud, Consejo Nacional de Investigaciones Científicas y Técnicas, Facultad de Ciencias Médicas Universidad Nacional de Córdoba Córdoba Argentina

2. Centro de Investigación y Desarrollo en Inmunología y Enfermedades Infecciosas, Consejo Nacional de Investigaciones Científicas y Técnicas Universidad Católica de Córdoba Córdoba Argentina

3. Servicio de Neurocirugía Hospital Privado Universitario de Córdoba Córdoba Argentina

Funder

Consejo Nacional de Investigaciones Científicas y Técnicas

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.30360

Reference51 articles.

1. Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

2. The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study

3. Pituitary somatostatin receptor signaling

4. Selective Regulation of Somatostatin Receptor Subtype Signaling: Evidence for Constitutive Receptor Activation

5. Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy;CNS Neuroscience & Therapeutics;2023-06-21

2. Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues;Cancer Cell International;2023-02-11